Hu Shuanggang, Sun Zhe, Li Boyu, Zhao Hanting, Wang Yuan, Yao Guangxin, Li Xinyu, Bian Xuejiao, Li Tin Chiu, Vankelecom Hugo, Sun Yun
Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Center for Reproductive Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200135, China.
Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, Hong Kong 999077, China.
Endocrinology. 2023 Jan 9;164(3). doi: 10.1210/endocr/bqad012.
Competent endometrial receptivity is a prerequisite for successful embryo implantation. Identification of novel key molecules involved in endometrial receptivity is essential to better interpret human implantation and improve pregnancy rates in assisted reproduction treatment. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics was performed to profile the proteomes of the prereceptive (luteinizing hormone [LH] + 2, n = 4) and receptive (LH + 7, n = 4) endometrial tissues. A total of 173 differentially expressed proteins (DEPs) between LH + 2 and LH + 7 endometrial samples were identified. Integrated analysis of the proteomic data and published transcriptomic data was performed to identify the concordant DEPs with differential expression at both the messenger RNA and protein levels. Protein-protein interaction (PPI) network analysis was performed on concordant DEPs. We first identified 63 novel concordant DEPs and 5 hub proteins (ACSL4, ACSL5, COL1A1, PTGS1, and PLA2G4F) between LH + 2 and LH + 7 endometrial samples. ACSL4 was predominantly expressed in endometrial epithelial cells and its expression was significantly upregulated by progesterone in the LH + 7 endometrium and significantly downregulated in repeated implantation failure patients. Knockdown of ACSL4 in endometrial epithelial cells induced the downregulation of endometrial receptivity markers (HOXA10, COX2, and LIF) and the significant decrease of implantation rate during in vitro implantation analysis. This study provides the first gel-independent quantitative proteomes of the LH + 2 and LH + 7 human endometrium using iTRAQ technology. The identified concordant DEPs and hub proteins open a new avenue for future studies aimed at elucidating the underlying mechanisms governing endometrial receptivity. ACSL4 was identified as a novel regulatory molecule in the establishment of endometrial receptivity and might play important roles during implantation.
具备良好的子宫内膜容受性是胚胎成功着床的前提条件。识别参与子宫内膜容受性的新型关键分子对于更好地理解人类着床过程以及提高辅助生殖治疗中的妊娠率至关重要。采用基于相对和绝对定量的等压标签(iTRAQ)蛋白质组学技术对未着床期(促黄体生成素[LH] + 2,n = 4)和着床期(LH + 7,n = 4)的子宫内膜组织蛋白质组进行分析。共鉴定出LH + 2和LH + 7子宫内膜样本之间173种差异表达蛋白(DEP)。对蛋白质组学数据和已发表的转录组学数据进行综合分析,以识别在信使核糖核酸和蛋白质水平均有差异表达的一致性DEP。对一致性DEP进行蛋白质-蛋白质相互作用(PPI)网络分析。我们首先在LH + 2和LH + 7子宫内膜样本之间鉴定出63种新型一致性DEP和5种枢纽蛋白(ACSL4、ACSL5、COL1A1、PTGS1和PLA2G4F)。ACSL4主要在内膜上皮细胞中表达,其表达在LH + 7子宫内膜中被孕酮显著上调,而在反复着床失败患者中显著下调。在体外着床分析中,敲低子宫内膜上皮细胞中的ACSL4会导致子宫内膜容受性标志物(HOXA10、COX2和LIF)下调以及着床率显著降低。本研究首次使用iTRAQ技术对LH + 2和LH + 7人子宫内膜进行了非凝胶定量蛋白质组分析。所鉴定出的一致性DEP和枢纽蛋白为未来旨在阐明子宫内膜容受性潜在机制的研究开辟了新途径。ACSL4被确定为子宫内膜容受性建立过程中的一种新型调节分子,可能在着床过程中发挥重要作用。